Skip Navigation Linksdefault


DiCE Molecules is a privately-held company focused on the development of small molecule compounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. Utilizing its unique approach, DiCE Molecules can amplify the strongest potential drug candidates and, by combining massive diversity with amplification and selection, substantially increase the probability of success.